These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 20815110)
1. Atorvastatin for reduction of myocardial damage during angioplasty trials. Nusca A; Melfi R; Patti G; Di Sciascio G J Cardiovasc Med (Hagerstown); 2010 Oct; 11(10):709-11. PubMed ID: 20815110 [No Abstract] [Full Text] [Related]
2. [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention]. Patti G; Pasceri V; Nusca A; Di Sciascio G Ital Heart J Suppl; 2005 Sep; 6(9):553-60. PubMed ID: 16281714 [TBL] [Abstract][Full Text] [Related]
3. Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. Patti G; Chello M; Gatto L; Alfano G; Miglionico M; Covino E; Di Sciascio G J Cardiovasc Med (Hagerstown); 2010 Nov; 11(11):795-800. PubMed ID: 20613550 [TBL] [Abstract][Full Text] [Related]
5. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903 [TBL] [Abstract][Full Text] [Related]
6. Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation. Shechter M Circulation; 2003 Jun; 107(22):e210; author reply e210. PubMed ID: 12796420 [No Abstract] [Full Text] [Related]
7. [The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting]. Han YL; Li CY; Li Y; Kang J; Yan CH Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Sep; 35(9):788-92. PubMed ID: 18070466 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. Kim JS; Kim J; Choi D; Lee CJ; Lee SH; Ko YG; Hong MK; Kim BK; Oh SJ; Jeon DW; Yang JY; Cho JR; Lee NH; Cho YH; Cho DK; Jang Y JACC Cardiovasc Interv; 2010 Mar; 3(3):332-9. PubMed ID: 20298994 [TBL] [Abstract][Full Text] [Related]
9. Concurrent use of clopidogrel (Plavix) and atorvasatin (Lipitor) is contraindicated. Chetty N; Naran NH; Munster M S Afr Med J; 2006 Apr; 96(4):264. PubMed ID: 16670787 [No Abstract] [Full Text] [Related]
10. Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. Mitsios JV; Papathanasiou AI; Rodis FI; Elisaf M; Goudevenos JA; Tselepis AD Circulation; 2004 Mar; 109(11):1335-8. PubMed ID: 15023882 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the atorvastatin-clopidogrel drug-drug interaction. Lau WC; Carville DG; Bates ER Circulation; 2004 Aug; 110(6):e66-7; author reply e66-7. PubMed ID: 15302813 [No Abstract] [Full Text] [Related]
12. Comparison of low vs moderate dose of atorvastatin in clopidogrel resistance after coronary stenting in Korean patients with acute coronary syndrome. Hong SJ; Park JY; Kim KA; Ahn CM; Park JS; Kim YH; Shim WJ; Park SM; Lim DS Circ J; 2009 Jun; 73(6):1111-8. PubMed ID: 19372620 [TBL] [Abstract][Full Text] [Related]
13. [Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina]. Shen J; Zhang RY; Zhang Q Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Sep; 36(9):807-11. PubMed ID: 19102862 [TBL] [Abstract][Full Text] [Related]
14. Potential statin-clopidogrel interaction requires more study. Williams D; Ford I; Hawksworth G Circulation; 2004 Aug; 110(6):e68; author reply e68. PubMed ID: 15302814 [No Abstract] [Full Text] [Related]
15. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Bloom JM N Engl J Med; 1999 Dec; 341(24):1854-5. PubMed ID: 10610466 [No Abstract] [Full Text] [Related]
16. Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation). Poyet R; Cuisset T; Frere C; Quilici J; Gaborit B; Moro PJ; Camoin L; Morange PE; Bonnet JL; Alessi MC Thromb Res; 2010 Nov; 126(5):e397-9. PubMed ID: 20825983 [No Abstract] [Full Text] [Related]
17. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. Wienbergen H; Gitt AK; Schiele R; Juenger C; Heer T; Meisenzahl C; Limbourg P; Bossaller C; Senges J; Am J Cardiol; 2003 Aug; 92(3):285-8. PubMed ID: 12888133 [TBL] [Abstract][Full Text] [Related]
18. The year in non-ST-segment elevation acute coronary syndromes. Giugliano RP; Braunwald E J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191 [No Abstract] [Full Text] [Related]
19. Myonecrosis after elective percutaneous coronary intervention: effect of clopidogrel-statin interaction. Gulec S; Ozdol C; Rahimov U; Atmaca Y; Kumbasar D; Erol C J Invasive Cardiol; 2005 Nov; 17(11):589-93. PubMed ID: 16264203 [TBL] [Abstract][Full Text] [Related]
20. Prevention of myocardial damage during coronary intervention. Pasceri V; Patti G; Di Sciascio G Cardiovasc Hematol Disord Drug Targets; 2006 Jun; 6(2):77-83. PubMed ID: 16787193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]